These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26020511)
1. Anti-cancer activity of withaferin A in B-cell lymphoma. McKenna MK; Gachuki BW; Alhakeem SS; Oben KN; Rangnekar VM; Gupta RC; Bondada S Cancer Biol Ther; 2015; 16(7):1088-98. PubMed ID: 26020511 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A. Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809 [TBL] [Abstract][Full Text] [Related]
3. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A. Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225 [TBL] [Abstract][Full Text] [Related]
4. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells. Hahm ER; Lee J; Huang Y; Singh SV Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907 [TBL] [Abstract][Full Text] [Related]
5. Withaferin A modulates the Spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines. Das T; Roy KS; Chakrabarti T; Mukhopadhyay S; Roychoudhury S Biochem Pharmacol; 2014 Sep; 91(1):31-9. PubMed ID: 24995417 [TBL] [Abstract][Full Text] [Related]
6. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells. Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401 [TBL] [Abstract][Full Text] [Related]
7. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells. Hahm ER; Singh SV Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597 [TBL] [Abstract][Full Text] [Related]
8. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers. Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382 [TBL] [Abstract][Full Text] [Related]
10. Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. Xia S; Miao Y; Liu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2363-2369. PubMed ID: 29966656 [TBL] [Abstract][Full Text] [Related]
11. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676 [No Abstract] [Full Text] [Related]
12. Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis. Tang Q; Ren L; Liu J; Li W; Zheng X; Wang J; Du G Cell Prolif; 2020 Jan; 53(1):e12706. PubMed ID: 31642559 [TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer. Hahm ER; Kim SH; Singh KB; Singh K; Singh SV Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824 [TBL] [Abstract][Full Text] [Related]
14. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo. Yang H; Wang Y; Cheryan VT; Wu W; Cui CQ; Polin LA; Pass HI; Dou QP; Rishi AK; Wali A PLoS One; 2012; 7(8):e41214. PubMed ID: 22912669 [TBL] [Abstract][Full Text] [Related]
15. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A. Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561 [TBL] [Abstract][Full Text] [Related]
16. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone. Vyas AR; Singh SV AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237 [TBL] [Abstract][Full Text] [Related]
17. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Yu Y; Hamza A; Zhang T; Gu M; Zou P; Newman B; Li Y; Gunatilaka AA; Zhan CG; Sun D Biochem Pharmacol; 2010 Feb; 79(4):542-51. PubMed ID: 19769945 [TBL] [Abstract][Full Text] [Related]
18. Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation. Samadi AK; Cohen SM; Mukerji R; Chaguturu V; Zhang X; Timmermann BN; Cohen MS; Person EA Tumour Biol; 2012 Aug; 33(4):1179-89. PubMed ID: 22477711 [TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharides-stimulated macrophage products enhance Withaferin A-induced apoptosis via activation of caspases and inhibition of NF-κB pathway in human cancer cells. Piao L; Canguo Z; Wenjie L; Xiaoli C; Wenli S; Li L Mol Immunol; 2017 Jan; 81():92-101. PubMed ID: 27915154 [TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract. Sinha P; Ostrand-Rosenberg S Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]